Apologies that are offered in a spirit of abundance are worlds apart from those all-too-common hangdog admissions of guilt ...
Neurogene reports interim Phase 1/2 trial results for NGN-401 gene therapy in treating pediatric Rett syndrome, showing ...
Greenwich Hospital is offering a new outpatient program for teen mental health after finding 'extreme rates of anxiety and ...
U.S. NeuroStar Advanced Therapy System revenue for the three months ended September 30, 2024 was $4.1 million, an increase of 14% compared to $3.6 million in the third quarter of 2023. For the three ...
Central, Hong Kong - Maple Tree Counselling, a counselling and therapy practice based in Central, Hong Kong, now boasts more ...
Family-based therapy can be effective for autistic children with anorexia, but let's explore what accommodations can be made ...
Egypt: A recent randomized controlled trial has demonstrated that sitagliptin, a DPP-4 inhibitor, significantly improves ...
NYU Grossman School of Medicine offers a 12-month Autism Spectrum Disorder and Neurodevelopmental Disorders Fellowship in the ...
GlobalData on MSN2d
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticariaThe FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
Several clinicians pivotal to the Cass Review recently addressed the Society for Evidence-Based Gender Medicine, a designated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback